Reuters
23 Jul 2026, 21:39 UTC · 2h ago
Edwards Lifesciences beats quarterly estimates on strong demand for heart devices
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Reuters
23 Jul 2026, 21:39 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Edwards Lifesciences exceeded analyst estimates for second-quarter profit and revenue. — Earnings and revenue beats typically signal stronger-than-expected fundamental performance, driving stock price appreciation.
+0.60The company experienced strong demand for artificial heart valves used in complex cardiac procedures. — Strong product demand indicates market share strength and provides a catalyst for future revenue growth.
+0.40Which stocks this story touches
The company beat profit and revenue estimates and saw a share price increase due to strong demand for heart valves.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
53m ago
